The 2 Biggest Casualties From the Celgene-Bristol-Myers Merger (So Far)

The 2 Biggest Casualties From the Celgene-Bristol-Myers Merger (So Far)

Source: 
Yahoo/Motley Fool
snippet: 

Celgene (NASDAQ: CELG) and Bristol-Myers Squibb (NYSE: BMY) were scheduled to say their official "I dos" in the coming months, but this blended family isn't starting off in Brady Bunch fashion.